Artificial Intelligence-Based Cognitive Training in Patients With Stroke

ConditionsPost-Stroke Cognitive Impairment (PSCI)Stroke Artifical Intelligence

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age45-60

SponsorOmima Alaa Eldin Hussein

About this trial

This study would answer the following question:Does AI application-based training improve cognitive function in Patients with Stroke?

The aims of this study:

To investigate the efficacy of AI application-based training on cognitive function in stroke patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient's age will range from 45- 60 years.

Diagnosis of stroke in the chronic stage (≥3 months post-onset).

Presence of cognitive impairment confirmed by a Montreal Cognitive Assessment (MoCA) score ≤ 26.

Medically stable and able to follow instructions.

Disqualifiers

Severe visual, hearing, or speech impairments prevent participation.

History of other neurological or psychiatric disorders.

Unstable cardiovascular or systemic disease.

Severe depression (Beck Depression Inventory > 29).

Trial design

Design model

Parallel

Treatments tested in this trial

cognifit Mobile Application for Cognitive Training
Device
A structured artificial intelligence-based cognitive training program targeting attention, memory, executive function, and processing speed in patients with stroke. The program provides adaptive, individualized exercises based on participant performance.
Conventional Cognitive Rehabilitation
Behavioral
A structured conventional rehabilitation program consisting of aerobic exercises, relaxation exercises, and traditional paper-based cognitive exercises for patients with stroke. The duration and frequency of treatment are matched to the experimental group.

Treatment groups

40 Participants

are divided into 2 treatment groups

Group A: AI-Based Cognitive TrainingExperimental treatment 1 intervention

Group B: Conventional Physical TherapyActive comparator 1 intervention

Trial outcomes

Primary outcomes

Change in Cognitive Function

Change in Global Cognitive Function Measured by the Montreal Cognitive Assessment (MoCA) Global cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA), a one-page, 30-point cognitive screening tool that evaluates attention, memory, executive function, language, visuospatial abilities, abstraction, calculation, and orientation. The test takes approximately 10 minutes to administer. Scores range from 0 to 30, with higher scores indicating better cognitive function. A score of less than 26 indicates cognitive impairment.

Time frame

Baseline and 6 weeks post-intervention

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Omima Alaa Eldin Hussein

Lead sponsor

Cairo University

Sponsor institution

Source ClinicalTrials.gov

Apply now